Development and Initial Validation of a Systemic Lupus Erythematosus-Specific Measure of the Extent of and Reasons for Medication Nonadherence.
Kai SunTheresa M ColesCorrine I VoilsD Ryan AndersonAmanda M EudyRebecca E SadunJennifer L RogersLisa G Criscione-SchreiberJayanth DossMithu MaheswaranathanMegan E B ClowsePublished in: The Journal of rheumatology (2022)
Our results support the reliability and validity of DOSE-Nonadherence for SLE medications. This refined instrument, DOSE-Nonadherence-SLE, can be used to identify, rigorously study, and guide adherence intervention development in SLE.